Literature DB >> 12571759

Evaluation of a population-based prevention program against influenza among Swiss elderly people.

Jean-Christophe Luthi1, François Méan, Catherine Ammon, Bernard Burnand.   

Abstract

INTRODUCTION: Influenza is a major cause of morbidity and mortality and occurs in epidemics in the winter. This study is an evaluation of a population-based prevention program against Influenza, implemented during autumn 2000 by the Health Department of the Canton of Vaud.
METHODS: A pre-intervention/post-intervention design was used. In June 2000 and March 2001, 4007 questionnaires were sent to two different stratified random samples of people aged 65 and over living in the Canton of Vaud, Switzerland. Univariate, bivariate and multivariate analyses were performed.
RESULTS: Vaccination coverage among people older than 65 was 58.0% in 1999 (95% CI: 56.2%-59.8%) and 58.4% (95% CI: 56.6%-60.2%) in 2000. A 6.5% significant increase in vaccination coverage was seen in the group of people aged 65 to 69 (p = 0.008). In the pre-intervention survey immunisation rates were 22.6% among people who had not consulted a physician, 59.2% among those who had consulted a physician once, and 73.2% among those who consulted twice or more (p = 0.001). These rates were respectively 30.8%, 58.0% and 75.1% (p = 0.001) in the post-intervention survey.
CONCLUSIONS: No global increase in Influenza vaccination coverage in the elderly population could be observed following a community based intervention in a Swiss Canton. However, the enhanced vaccination rates noted in the 65-69 years old group and in people who did not receive medical care are compatible with an effect of the campaign. Further increase in vaccination coverage may be obtained by diversification and repetition of such promotion campaigns.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12571759     DOI: 2002/41/smw-10087

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  1 in total

1.  Viral vaccine meeting held in Barcelona, October 25-28, 2003.

Authors:  A C M Boon; S Plotkin; G F Rimmelzwaan; A D M E Osterhaus
Journal:  Vaccine       Date:  2004-03-29       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.